Roche MS drug Ocrevus approved by FDA after three-month delay
FOX News
The U.S. Food and Drug Administration (FDA) on Tuesday approved Roche Holding AG's multiple sclerosis (MS) drug Ocrevus, putting the potential blockbuster drug back on track after a delay caused by regulators' concerns over manufacturing issues.
There is not enough evidence to encourage or discourage doctors from testing all their patients for celiac disease, according to a U.S. government-backed panel.
A paralyzed man in Cleveland fed himself mashed potatoes for the first time in eight years, aided by a computer-brain interface that reads his thoughts and sends signals to move muscles in his arm, U.S. researchers said on Tuesday.
Juan Pedro is expected to lose up to 50 percent of his remaining weight in the next six months.
An outbreak of meningitis in Nigeria has killed 269 people in recent weeks, the Nigeria Centre for Disease Control said, as Africa's most populous country and aid organizations attempt to tackle the surge in infections.
No comments:
Post a Comment